Conversely, central blockade of TLR4 reportedly reduced mean arterial blood pressure, suppressed production of pro-inflammatory mediators, and eventually attenuated cardiac hypertrophy (25, 26). This evidence concerns the gene TLR4 and cardiac hypertrophy.